Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers

Jan Lubiński; Henry T. Lynch; Rita Schmutzler; Monique M.A. Brood-Van Zanten; Marius J. Van Der Mooren; René H.M. Verheijen; Peter Kenemans; Tracy Dudding; Judy Kirk; Shirley Hodgson; Lenka Foretova; Barbara Weber; Timothy R. Rebbeck; Jill E. Stopfer; Susan Domchek

Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers

Jan Lubiński, Henry T. Lynch, Rita Schmutzler, Monique M.A. Brood-Van Zanten, Marius J. Van Der Mooren, René H.M. Verheijen, Peter Kenemans, Tracy Dudding, Judy Kirk, Shirley Hodgson, Lenka Foretova, Barbara Weber, Timothy R. Rebbeck, Jill E. Stopfer, Susan Domchek

Department of Preventive Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	87-91
Number of pages	5
Journal	Hereditary Cancer in Clinical Practice
Volume	3
Issue number	3
State	Published - 2005

All Science Journal Classification (ASJC) codes

Oncology
Genetics(clinical)

Cite this

Lubiński, J., Lynch, H. T., Schmutzler, R., Brood-Van Zanten, M. M. A., Van Der Mooren, M. J., Verheijen, R. H. M., Kenemans, P., Dudding, T., Kirk, J., Hodgson, S., Foretova, L., Weber, B., Rebbeck, T. R., Stopfer, J. E., & Domchek, S. (2005). Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers. Hereditary Cancer in Clinical Practice, 3(3), 87-91.

Lubiński, J, Lynch, HT, Schmutzler, R, Brood-Van Zanten, MMA, Van Der Mooren, MJ, Verheijen, RHM, Kenemans, P, Dudding, T, Kirk, J, Hodgson, S, Foretova, L, Weber, B, Rebbeck, TR, Stopfer, JE & Domchek, S 2005, 'Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers', Hereditary Cancer in Clinical Practice, vol. 3, no. 3, pp. 87-91.

@article{9add5e8cb5554c95b9efd426b36a88b7,

title = "Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers",

author = "Jan Lubi{\'n}ski and Lynch, {Henry T.} and Rita Schmutzler and {Brood-Van Zanten}, {Monique M.A.} and {Van Der Mooren}, {Marius J.} and Verheijen, {Ren{\'e} H.M.} and Peter Kenemans and Tracy Dudding and Judy Kirk and Shirley Hodgson and Lenka Foretova and Barbara Weber and Rebbeck, {Timothy R.} and Stopfer, {Jill E.} and Susan Domchek",

year = "2005",

language = "English (US)",

volume = "3",

pages = "87--91",

journal = "Hereditary Cancer in Clinical Practice",

issn = "1731-2302",

publisher = "BioMed Central",

number = "3",

}

TY - JOUR

T1 - Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers

AU - Lubiński, Jan

AU - Lynch, Henry T.

AU - Schmutzler, Rita

AU - Brood-Van Zanten, Monique M.A.

AU - Van Der Mooren, Marius J.

AU - Verheijen, René H.M.

AU - Kenemans, Peter

AU - Dudding, Tracy

AU - Kirk, Judy

AU - Hodgson, Shirley

AU - Foretova, Lenka

AU - Weber, Barbara

AU - Rebbeck, Timothy R.

AU - Stopfer, Jill E.

AU - Domchek, Susan

PY - 2005

Y1 - 2005

UR - http://www.scopus.com/inward/record.url?scp=33745256713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745256713&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:33745256713

VL - 3

SP - 87

EP - 91

JO - Hereditary Cancer in Clinical Practice

JF - Hereditary Cancer in Clinical Practice

SN - 1731-2302

IS - 3

ER -

Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers

All Science Journal Classification (ASJC) codes

Other files and links

Cite this